Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor

被引:40
|
作者
Chen, Quan [1 ]
Miller, Laurence J. [1 ]
Dong, Maoqing [1 ]
机构
[1] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2010年 / 299卷 / 01期
关键词
G protein-coupled receptor; ligand binding; receptor biological activity; receptor cell surface expression; CELL-SURFACE EXPRESSION; PROTEIN-COUPLED RECEPTORS; SECRETIN RECEPTOR; LIGAND-BINDING; AT(1) RECEPTOR; OLIGOSACCHARIDES; ACTIVATION; DOMAIN; SITES;
D O I
10.1152/ajpendo.00067.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chen Q, Miller LJ, Dong M. Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor. Am J Physiol Endocrinol Metab 299: E62-E68, 2010. First published April 20, 2010; doi:10.1152/ajpendo.00067.2010.-The family B G protein-coupled glucagon-like peptide 1 (GLP-1) receptor is an important drug target for treatment of type 2 diabetes. Like other family members, the GLP-1 receptor is a glycosylated membrane protein that contains three potential sites for N-linked glycosylation within the functionally important extracellular amino-terminal domain. However, the roles for each potential site of glycosylation in receptor biosynthesis, trafficking, and function are not known. In this work, we demonstrated that tunicamycin inhibition of glycosylation of the GLP-1 receptor expressed in CHO cells interfered with biosynthesis and intracellular trafficking, thereby eliminating natural ligand binding. To further investigate the roles of each of the glycosylation sites, site-directed mutagenesis was performed to eliminate these sites individually and in aggregate. Our results showed that mutation of each of the glycosylation sites individually did not interfere with receptor expression on the cell surface, ligand binding, and biological activity. However, simultaneous mutation of two or three glycosylation sites resulted in almost complete loss of GLP-1 binding and severely impaired biological activity. Immunostaining studies demonstrated receptor biosynthesis but aberrant trafficking, with most of the receptor trapped in the endoplasmic reticulum and golgi compartments and little of the receptor expressed on the cell surface. Interestingly, surface expression, ligand binding, and biological activity of these mutants improved significantly when biosynthesis was slowed using low temperature (30 degrees C). These data suggest that N-linked glycosylation of the GLP-1 receptor is important for its normal folding and trafficking to the cell surface.
引用
收藏
页码:E62 / E68
页数:7
相关论文
共 50 条
  • [1] Functional role of N-linked glycosylation on the rat melanin-concentrating hormone, receptor 1
    Saito, Y
    Tetsuka, M
    Yue, L
    Kawamura, Y
    Maruyama, K
    FEBS LETTERS, 2003, 533 (1-3) : 29 - 34
  • [2] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730
  • [3] Role of N-Linked Glycosylation in PKR2 Trafficking and Signaling
    Verdinez, Jissele A.
    Sebag, Julien A.
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [4] The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased Agonists
    Fang, Zijian
    Chen, Shiqian
    Pickford, Philip
    Broichhagen, Johannes
    Hodson, David J.
    Correa, Ivan R., Jr.
    Kumar, Sunil
    Gorlitz, Frederik
    Dunsby, Chris
    French, Paul M. W.
    Rutter, Guy A.
    Tan, Tricia
    Bloom, Stephen R.
    Tomas, Alejandra
    Ben Jones
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (02) : 345 - 360
  • [5] Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor
    Hennen, Stephanie
    Kodra, Janos T.
    Soroka, Vladyslav
    Krogh, Berit O.
    Wu, Xiaoai
    Kaastrup, Peter
    Orskov, Cathrine
    Ronn, Sif G.
    Schluckebier, Gerd
    Barbateskovic, Silvia
    Gandhi, Prafull S.
    Reedtz-Runge, Steffen
    SCIENTIFIC REPORTS, 2016, 6
  • [6] Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor
    Huang, Y.
    Wilkinson, G. F.
    Willars, G. B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (01) : 237 - 251
  • [7] Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Differentially Regulates Orthosteric but Not Allosteric Agonist Binding and Function
    Koole, Cassandra
    Wootten, Denise
    Simms, John
    Savage, Emilia E.
    Miller, Laurence J.
    Christopoulos, Arthur
    Sexton, Patrick M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (06) : 3659 - 3673
  • [8] Site of action of a pentapeptide agonist at the glucagon-like peptide-1 receptor. Insight into a small molecule agonist-binding pocket
    Dong, Maoqing
    Pinon, Delia I.
    Miller, Laurence J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 638 - 641
  • [9] Differential engagement of polar networks in the glucagon-like peptide 1 receptor by endogenous variants of the glucagon-like peptide 1
    Furness, S. G. B.
    Christopoulos, A.
    Sexton, P. M.
    Wootten, D.
    BIOCHEMICAL PHARMACOLOGY, 2018, 156 : 223 - 240
  • [10] Functional Consequences of Glucagon-like Peptide-1 Receptor Cross-talk and Trafficking
    Roed, Sarah Noerklit
    Nohr, Anne Cathrine
    Wismann, Pernille
    Iversen, Helle
    Brauner-Osborne, Hans
    Knudsen, Sanne Moeller
    Waldhoer, Maria
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (02) : 1233 - 1243